Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus

Journal of Cardiology

Volumn 64, Issue 6, 2014, Pages 450-455

  Lee, Ji Hyun ^a   Im Cho, Kyoung ^b  

^a Maryknoll Hospital   (South Korea)

^b Kosin University   (South Korea)

Author keywords

Arterial stiffness; Pulmonary hypertension; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PARAMETERS; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULSE WAVE; RAYNAUD PHENOMENON; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PULSATILE FLOW; TIBIAL ARTERY;

ANKLE BRACHIAL INDEX; ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PULSATILE FLOW; TIBIAL ARTERIES; VASCULAR STIFFNESS;

EID: 84926408277     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.030     Document Type: Article

References (34)

1. Pan T.L., Thumboo J., Boey M.L. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000, 9:338-342.
2. Simonson J.S., Schiller N.B., Petri M., Hellmann D.B. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989, 16:918-925.
3. Winslow T.M., Ossipov M.A., Fazio G.P., Simonson J.S., Redberg R.F., Schiller N.B. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995, 129:510-515.
4. Johnson S.R., Gladman D.D., Urowitz M.B., Ibanez D., Granton J.T. Pulmonary hypertension in systemic lupus. Lupus 2004, 13:506-509.
5. Quismorio F.P., Sharma O., Koss M., Boylen T., Edmiston A.W., Thornton P.J., Tatter D. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1994, 13:349-359.
6. Budhiraja R., Tuder R.M., Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 2004, 109:159-165.
7. Voelkel N.F., Cool C., Lee S.D., Wright L., Geraci M.W., Tuder R.M. Primary pulmonary hypertension between inflammation and cancer. Chest 1998, 114:225S-230S.
8. Tuder R.M., Groves B., Badesch D.B., Voelkel N.F. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994, 144:275-285.
9. Xia Y.K., Tu S.H., Hu Y.H., Wang Y., Chen Z., Day H.T., Ross K. Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population. Rheumatol Int 2013, 33:1211-1217.
10. Lian F., Chen D., Wang Y., Ye Y., Wang X., Zhan Z., Xu H., Liang L., Yang X. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatol Int 2012, 32:1727-1731.
11. Ames P.R., Margarita A., Delgado Alves J., Tommasino C., Iannaccone L., Brancaccio V. Anticardiolipin antibody titer and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002, 11:208-214.
12. Hasnie A.M., Stoddard M.F., Gleason C.B., Wagner S.G., Longaker R.A., Pierangeli S., Harris E.N. Diastolic dysfunction is a feature of the antiphospholipid syndrome. Am Heart J 1995, 129:1009-1013.
13. Hochberg M. Updating American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725-1734.
14. Lee J.H., Cho K.I., Kim S.M. Carotid arterial stiffness in patients with rheumatoid arthritis assessed by speckle tracking strain imaging: its association with carotid atherosclerosis. Clin Exp Rheumatol 2012, 30:720-728.
15. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., Koji Y., Hori S., Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulsewave velocity measurement. Hypertens Res 2002, 25:359-364.
16. Tomiyama H., Yamashita A., Arai T., Hirose K., Koji Y., Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12,517 subjects. Atherosclerosis 2003, 166:303-309.
17. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640.
18. Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. Clin Dev Immunol 2012, 2012:854941.
19. Shen J.Y., Chen S.L., Wu Y.X., Tao R.Q., Gu Y.Y., Bao C.D., Wang Q. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int 1999, 18:147-151.
20. Kasparian A., Floros A., Gialafos E., Kanakis M., Tassiopoulos S., Kafasi N., Vaiopoulos G. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007, 16:505-508.
21. Golemati S., Sassano A., Lever M.J., Bharath A.A., Dhanjil S., Nicolaides A.N. Carotid artery wall motion estimated from B-mode ultrasound using region tracking and block matching. Ultrasound Med Biol 2003, 29:387-399.
22. Laurent S., Boutouyrie P., Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005, 45:1050-1055.
23. Sandoval J., Bauerle O., Palomar A., Gómez A., Martínez-Guerra M.L., Beltrán M., Guerrero M.L. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994, 89:1733-1744.
24. Badano L.P., Ginghina C., Easaw J., Muraru D., Grillo M.T., Lancellotti P., Pinamonti B., Coghlan G., Marra M.P., Popescu B.A., De Vita S. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010, 11:27-37.
25. Fartoukh M., Emilie D., Le Gall C., Monti G., Simonneau G., Humbert M. Chemokine macrophage inflammatory protein 1-α mRNA expression in lung biopsy specimens of primary pulmonary hypertension. Chest 1998, 114:50S-51S.
26. Humbert M., Monti G., Brenot F., Sitbon O., Portier A., Grangeot-Keros L., Duroux P., Galanaud P., Simonneau G., Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151:1628-1631.
27. Corti R., Badimon J.J. Biologic aspects of vulnerable plaque. Curr Opin Cardiol 2002, 17:616-625.
28. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?. Lupus 2008, 17:274-277.
29. Asherson R.A., Higenbottam T.W., Dinh Xuan A.T., Khamashta M.A., Hughes G.R. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990, 17:1292-1298.
30. Asherson R.A., Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 2007, 32:153-158.
31. Cefle A., Inanc M., Sayalioqlu M., Kamali S., Gul A., Ocal L., Aral O., Konice M. Pulmonary hypertension in patients with systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int 2011, 31:183-189.
32. Johnson S.R., Granton J.T. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev 2011, 20:277-286.
33. Isern R.A., Yaneva M., Weiner E., Parke A., Rothfield N., Dantzker D., Rich S., Arnett F.C. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992, 93:307-312.
34. Shang Q., Yip G.W., Tam L.S., Zhang Q., Sanderson J.E., Lam Y.Y., Li C.M., Wang T., Li E.K., Yu C.M. SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus. Lupus 2012, 21:1057-1062.